Tehran University of Medical Sciences

Science Communicator Platform

Faculty Members have conducted research related to the Efficacy and Safety of a Proposed Omalizumab Biosimilar Compared to the Reference Product in the Management of Uncontrolled Moderate-To-Severe Allergic Asthma: A Multicenter, Phase Iii, Randomized, Double-Blind, Equivalency Clinical Trial
Mohsen Jafari

Assistant Professor of Pediatric Infectious Disease

Department Pediatrics

School of Medicine

Bahrami Hospital

Tehran University of Medical Sciences

Related Documents
All Documents
12. Covid-19 in Iga Vasculitis, Iranian Journal of Pediatrics (2020)